Skip to content
Trial Eligibility
Menu

Longitudinal Sexual and Reproductive Health Study of Women With Breast Cancer and Lymphoma

NCT01788839

This study is recruiting at 7 US sites in 2 states, according to its ClinicalTrials.gov record last updated .

Summary

The purpose of this study is to see how cancer treatment affects sexual and reproductive function. The patient will also be asked to participate in blood draws to see if and how cancer treatment affects the ovaries and the ability to have children (fertility). These blood draws are optional and the patient can still participate in the questionnaire portion of the study even if they choose not to have their blood drawn.

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

  • Breast Cancer
  • Lymphoma
  • Hodgkin's Lymphoma

Eligibility basics and study details

Study type
Observational
Phase
Not applicable
Ages
18 years and older
Sex
Female
Healthy volunteers
Not accepted
Sponsor
Memorial Sloan Kettering Cancer Center
Last updated on ClinicalTrials.gov
March 4, 2026

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites

New Jersey · 3

  • Memorial Sloan Kettering Basking Ridge · Basking Ridge, NJ
  • Memorial Sloan Kettering Monmouth · Middletown, NJ
  • Memorial Sloan Kettering Bergen · Montvale, NJ

New York · 4

  • Memorial Sloan Kettering Commack · Commack, NY
  • Memorial Sloan Kettering Westchester · Harrison, NY
  • Memorial Sloan Kettering Cancer Center · New York, NY
  • Memorial Sloan Kettering Nassau · Uniondale, NY

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.